Text Size

Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by State University of New York - Downstate Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
State University of New York - Downstate Medical Center
ClinicalTrials.gov Identifier:
NCT00887666
First received: April 23, 2009
Last updated: NA
Last verified: April 2009
History: No changes posted
  Purpose

People with heart failure may have low magnesium and low vitamin D levels. They may also have abnormally high levels of parathyroid hormones. Magnesium and vitamin D are important chemicals that are not routinely measured in blood tests. We are studying how many people with heart failure have low levels of magnesium and vitamin D. We are also studying how many people with heart failure have overactive parathyroid glands and if that is related to their vitamin D levels.


Condition
Congestive Heart Failure
Hypovitaminosis D
Hypomagnesemia
Hyperparathyroidism

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by State University of New York - Downstate Medical Center:

Primary Outcome Measures:
  • Prevalence of hypovitaminosis D, Hyperparathyroidism, Hypomagnesemia in our cohort of CHF patients [ Time Frame: One year ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: October 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

People with congestive heart failure

Criteria

Inclusion Criteria:

  • congestive heart failure

Exclusion Criteria:

  • pregnant
  • hospitalized within one month
  • taking calcium, vitamin D or magnesium supplements
  • proteinuria > 1g/24h
  • creatinine clearance <35 (MDRD)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00887666

Contacts
Contact: Sima Terebelo, MPH, RPA-C 718-270-8216 sima.terebelo@downstate.edu

Locations
United States, New York
SUNY Downstate Medical Center Recruiting
Brooklyn, New York, United States, 11203
Sponsors and Collaborators
State University of New York - Downstate Medical Center
Investigators
Principal Investigator: Mariana Markell, MD State University of New York - Downstate Medical Center
  More Information

No publications provided

Responsible Party: Mariana Markell, MD, SUNY Downstate Medical Center
ClinicalTrials.gov Identifier: NCT00887666     History of Changes
Other Study ID Numbers: 07-121
Study First Received: April 23, 2009
Last Updated: April 23, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Rickets
Heart Failure
Hyperparathyroidism
Avitaminosis
Heart Diseases
Cardiovascular Diseases
Parathyroid Diseases
Endocrine System Diseases
Bone Diseases, Metabolic
 Bone Diseases
Musculoskeletal Diseases
Calcium Metabolism Disorders
Metabolic Diseases
Vitamin D Deficiency
Deficiency Diseases
Malnutrition
Nutrition Disorders

ClinicalTrials.gov processed this record on June 17, 2013